RxDoctor Payments Data

Amber Moss, DO

Family Medicine · Bristol, TNNPI 1386022630

Payments from drug & device makers

$982in general payments, 2019–2025

Across 63 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$339
  • AbbVie$160
  • GSK$81
  • AstraZeneca$76
  • EMD Serono, Inc.$73
  • Lilly USA, LLC$67
  • plus $187 from 8 others

What the payments were for

  • Food & beverage$982100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$982 in reported general payments places this provider in the 55th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$81,269
Medicare patients
234
Services billed
1,364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide148$204,815
FarxigaDapagliflozin Propanediol70$65,725
EliquisApixaban40$43,279
MounjaroTirzepatide11$15,754
JardianceEmpagliflozin17$14,496
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$13,289
Spiriva HandihalerTiotropium Bromide21$13,097
XareltoRivaroxaban17$12,092
Breo ElliptaFluticasone/Vilanterol18$7,964
Spiriva RespimatTiotropium Bromide14$6,991
Atorvastatin Calcium332$4,686
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$4,384
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$3,016
Duloxetine Hcl73$2,901
Ezetimibe76$2,466

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$339$204,815148 claims
AstraZenecaFarxiga$76$65,72570 claims
PfizerEliquis$17$43,27940 claims
GSKTrelegy Ellipta, Breo Ellipta$81$21,25337 claims
Lilly USA, LLCMounjaro$67$15,75411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Bristol

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →